Chemistry:Lecozotan

Lecozotan
Identifiers
	IUPAC name 4-Cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl]propyl]-N-2-pyridinylbenzamide hydrochloride;
CAS Number	434283-16-6;
PubChem CID	10116877;
ChemSpider	8292400;
UNII	48854OTZ5E;
KEGG	D04683 ;
ChEMBL	ChEMBL372205;
Chemical and physical data
Formula	C28H30ClN5O3
Molar mass	520.03 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H](CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5;
	InChI InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1; Key:NRPQELCNMADTOZ-OAQYLSRUSA-N;
	(verify)

Short description: Chemical compound

Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients.^[1] (As of June 2008), the first Phase III clinical trial has been completed.^[2]

Method of action

Lecozotan is a competitive, selective 5-HT_1A receptor antagonist^[3] which enhances the potassium-stimulated release of acetylcholine and glutamate.^[4]

References

↑ "Neue Wirkstoffe - Lecozotan" (in German). Österreichische Apothekerzeitung (17/2007): 805. August 13, 2008.
↑ ClinicalTrials
↑ "Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties". The Journal of Pharmacology and Experimental Therapeutics 314 (3): 1274–89. September 2005. doi:10.1124/jpet.105.086363. PMID 15951399. http://jpet.aspetjournals.org/cgi/content/short/jpet.105.086363v1.
↑ "Lecozotan Hydrochloride". Drugs of the Future 32 (5): 399–407. 2007. doi:10.1358/dof.2007.032.05.1092901. http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1092901&p_IsPs=N.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Lecozotan. Read more

[1] "Neue Wirkstoffe - Lecozotan" (in German). Österreichische Apothekerzeitung (17/2007): 805. August 13, 2008.

[2] ClinicalTrials

[3] "Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties". The Journal of Pharmacology and Experimental Therapeutics 314 (3): 1274–89. September 2005. doi:10.1124/jpet.105.086363. PMID 15951399. http://jpet.aspetjournals.org/cgi/content/short/jpet.105.086363v1.

[4] "Lecozotan Hydrochloride". Drugs of the Future 32 (5): 399–407. 2007. doi:10.1358/dof.2007.032.05.1092901. http://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1092901&p_IsPs=N.

[1]

[2]

[3]

[4]

v t e Psychoanaleptics: Anti-dementia agents (ATC code N06D and others)
AChE inhibitor medications	Donepezil Galantamine Ipidacrine Rivastigmine Tacrine
Other medications	Bifemelane Ginkgo folium Meclofenoxate (centrophenoxine) Memantine Nicergoline
Experimental BACE inhibitors	Lanabecestat Verubecestat

Anonymous

Search

Chemistry:Lecozotan

Namespaces

More

Page actions

Method of action

References

Navigation

Navigation

Help

Translate

Wiki tools

Wiki tools

Identifiers

IUPAC name 4-Cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl]propyl]-N-2-pyridinylbenzamide hydrochloride
CAS Number	434283-16-6
PubChem CID	10116877
ChemSpider	8292400
UNII	48854OTZ5E
KEGG	D04683^Y
ChEMBL	ChEMBL372205
Chemical and physical data
Formula	C₂₈H₃₀ClN₅O₃
Molar mass	520.03 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C[C@H](CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5
InChI InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1 Key:NRPQELCNMADTOZ-OAQYLSRUSA-N
(verify)

Anonymous

Search

Chemistry:Lecozotan

Method of action

References

Navigation

Wiki tools

Page tools

Other projects

Categories